Daily Bulletin


The Conversation

  • Written by Deborah Gleeson, Senior Lecturer in Public Health, La Trobe University
Three simple things Australia should do to secure access to treatments, vaccines, tests and devices during the coronavirus crisis

Patents and related intellectual property rights can present formidable barriers to procuring medicines, vaccines, diagnostic tests and medical devices.

They can cost lives, particularly during a public health emergency.

Two examples from the United States illustrate the point.

The US conglomerate 3M holds hundreds of patents on N95 face masks. The Governor of Kentucky has asked it to release them so other manufacturers can make the masks.

Gilead Sciences holds a range of patents for remdesivir, one of the leading candidates for treating COVID-19.

Read more: Drug companies should drop their patents and collaborate to fight coronavirus

It recently applied for an extra period of exclusivity which would have extended the length of time other firms were prevented from manufacturing the drug without its permission. It withdrew its application after a public outcry.

In the past few weeks 150 civil society organisations, including Médecins Sans Frontières, have called on Gilead to forgo its patents.

There are three things Australia should do to manage these sorts of situations.

1. Prepare to over-ride patents

First, Australia should prepare to take advantage of some rarely-used but vitally important safeguards in the Commonwealth Patents Act.

They enable patents to be over-ridden when necessary to prevent shortages of vital medical supplies.

Under Sections 132-133, the Federal Court can order that a compulsory license be granted for a patented invention, meaning that a third party (such as a company that produces generic medicines or face masks) can manufacture copies of the invention without the permission of the patent owner.

This can be done under conditions outlined in Section 133, Para 3, which include that

  • demand in Australia for the original invention is not being met on reasonable terms

  • authorisation to exploit the original invention is essential to meet that demand

  • the applicant has tried for a reasonable period, but without success, to obtain authority from the patentee to exploit the original invention on reasonable terms and conditions

  • the patentee has given no satisfactory reason for failing to exploit the patent to the extent necessary to meet the demand for the original invention in Australia

Although the requirement that the applicant has tried for a reasonable period without success to obtain authority can slow down the process, the World Trade Organisation’s Agreement on Trade-Related Intellectual Property Rights allows for legislation that bypasses the need for negotiations in an emergency.

Last month Canada passed such legislation, specifying that it was for the period of the coronavirus emergency.

Read more: Canada's coronavirus aid package guards against drug shortages with compulsory licensing

Australia should consider doing the same.

The Patent Act’s crown use provisions (Sections 163-170) provide another (potentially easier) mechanism allowing Australian governments to over-ride a patent in an emergency in order to provide a service primarily provided or funded by a government.

These provisions could also be redrafted to reduce ambiguity and make them easier to use in an emergency.

Using these provisions, particularly if they are made more workable, could mean that medical technologies could be manufactured locally if there are shortages or if they are not available from the patent holder at a reasonable price.

2. Reinstate the right to import low-cost medicines

Australia should also reverse its earlier decision to voluntarily waive its right to import medicines manufactured in another country under a compulsory license.

If Australia doesn’t have the manufacturing capacity to produce a particular drug, or to produce enough of it to meet its population’s needs, it should be able to import a low-cost version from another country.

To reverse the waiver, the Australian Government needs to notify the World Trade Organization that it has changed its policy and now considers itself an eligible importing country, at least in the context of an emergency.

3. Support Costa Rica’s proposal for a global COVID-19 pool

Finally, the Australian Government should follow The Netherlands in supporting Costa Rica’s proposal for a World Health Organization global pool for rights on data and knowledge that can be of use for the prevention, detection and treatment of COVID-19.

Now put forward by the European Union as a draft resolution for the World Health Assembly, the initiative aims to provide free access to existing knowledge about diagnostic tests, devices, drugs and vaccines, enabling all countries to quickly access or produce affordable products.

Read more: Supplies needed for coronavirus healthcare workers: 89 million masks, 30 million gowns, 2.9 million litres of hand sanitiser. A month.

Each of three simple practical actions could prevent intellectual property rights from becoming an insurmountable barrier to accessing essential products during the emergency.

Authors: Deborah Gleeson, Senior Lecturer in Public Health, La Trobe University

Read more https://theconversation.com/three-simple-things-australia-should-do-to-secure-access-to-treatments-vaccines-tests-and-devices-during-the-coronavirus-crisis-136052

Writers Wanted

Planning a road trip in a pandemic? 11 tips for before you leave, on the road and when you arrive

arrow_forward

Biden's cabinet picks are globally respected, but one obstacle remains for the US to 'lead the world' again

arrow_forward

The Conversation
INTERWEBS DIGITAL AGENCY

Politics

Prime Minister Interview with Ben Fordham, 2GB

BEN FORDHAM: Scott Morrison, good morning to you.    PRIME MINISTER: Good morning, Ben. How are you?    FORDHAM: Good. How many days have you got to go?   PRIME MINISTER: I've got another we...

Scott Morrison - avatar Scott Morrison

Prime Minister Interview with Kieran Gilbert, Sky News

KIERAN GILBERT: Kieran Gilbert here with you and the Prime Minister joins me. Prime Minister, thanks so much for your time.  PRIME MINISTER: G'day Kieran.  GILBERT: An assumption a vaccine is ...

Daily Bulletin - avatar Daily Bulletin

Did BLM Really Change the US Police Work?

The Black Lives Matter (BLM) movement has proven that the power of the state rests in the hands of the people it governs. Following the death of 46-year-old black American George Floyd in a case of ...

a Guest Writer - avatar a Guest Writer

Business News

Nisbets’ Collab with The Lobby is Showing the Sexy Side of Hospitality Supply

Hospitality supply services might not immediately make you think ‘sexy’. But when a barkeep in a moodily lit bar holds up the perfectly formed juniper gin balloon or catches the light in the edg...

The Atticism - avatar The Atticism

Buy Instagram Followers And Likes Now

Do you like to buy followers on Instagram? Just give a simple Google search on the internet, and there will be an abounding of seeking outcomes full of businesses offering such services. But, th...

News Co - avatar News Co

Cybersecurity data means nothing to business leaders without context

Top business leaders are starting to realise the widespread impact a cyberattack can have on a business. Unfortunately, according to a study by Forrester Consulting commissioned by Tenable, some...

Scott McKinnel, ANZ Country Manager, Tenable - avatar Scott McKinnel, ANZ Country Manager, Tenable



News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion